Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason M White

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
The Cochrane Database of Systematic Reviews|February 22, 2017
Buprenorphine for managing opioid withdrawalLinda Gowing, Robert Ali, Jason M White, et al.
Drug Testing and Analysis|July 23, 2015
Estimates of tobacco use by wastewater analysis of anabasine and anatabineBen J Tscharke, Jason M White, Jacobus P Gerber
The Cochrane Database of Systematic Reviews|May 4, 2016
Alpha₂-adrenergic agonists for the management of opioid withdrawalLinda Gowing, Michael Farrell, Robert Ali, et al.
Drug and Alcohol Dependence|March 14, 2003
Opioid effects and opioid withdrawal during a 24 h dosing interval in patients maintained on buprenorphineOlga V Lopatko, Jason M White, Alice Huber, et al.
The Medical Journal of Australia|July 14, 2017
Wastewater analysis shows a large decrease in oxycodone use in AdelaidePhilip Crowley, Jason M White, Benjamin J Tscharke, et al.
The Cochrane Database of Systematic Reviews|April 1, 2014
Alpha2-adrenergic agonists for the management of opioid withdrawalLinda Gowing, Michael F Farrell, Robert Ali, et al.
Forensic Science International|July 30, 2013
Increases in use of novel synthetic stimulant are not directly linked to decreased use of 3,4-methylenedioxy-N-methylamphetamine (MDMA)Chang Chen, Chris Kostakis, Rodney J Irvine, et al.
Journal of Substance Abuse Treatment|March 11, 2008
Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usualCatherine McGregor, Manit Srisurapanont, Amanda Mitchell, et al.
European Journal of Pain (London, England)|February 12, 2008
Antinociceptive effects of high-dose remifentanil in male methadone-maintained patientsJustin L Hay, Jason M White, Felix Bochner, et al.
Drug Testing and Analysis|January 10, 2024
Amphetamine-type drug-related fatalities in the context of 8 years of methamphetamine use measured by wastewater analysis in South AustraliaEmma L Jaunay, Bradley S Simpson, Jason M White, et al.
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
The Cochrane Database of Systematic Reviews|February 22, 2017
Buprenorphine for managing opioid withdrawalLinda Gowing, Robert Ali, Jason M White, et al.
Drug Testing and Analysis|July 23, 2015
Estimates of tobacco use by wastewater analysis of anabasine and anatabineBen J Tscharke, Jason M White, Jacobus P Gerber
The Cochrane Database of Systematic Reviews|May 4, 2016
Alpha₂-adrenergic agonists for the management of opioid withdrawalLinda Gowing, Michael Farrell, Robert Ali, et al.
Drug and Alcohol Dependence|March 14, 2003
Opioid effects and opioid withdrawal during a 24 h dosing interval in patients maintained on buprenorphineOlga V Lopatko, Jason M White, Alice Huber, et al.
The Medical Journal of Australia|July 14, 2017
Wastewater analysis shows a large decrease in oxycodone use in AdelaidePhilip Crowley, Jason M White, Benjamin J Tscharke, et al.
The Cochrane Database of Systematic Reviews|April 1, 2014
Alpha2-adrenergic agonists for the management of opioid withdrawalLinda Gowing, Michael F Farrell, Robert Ali, et al.
Forensic Science International|July 30, 2013
Increases in use of novel synthetic stimulant are not directly linked to decreased use of 3,4-methylenedioxy-N-methylamphetamine (MDMA)Chang Chen, Chris Kostakis, Rodney J Irvine, et al.
Journal of Substance Abuse Treatment|March 11, 2008
Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usualCatherine McGregor, Manit Srisurapanont, Amanda Mitchell, et al.
European Journal of Pain (London, England)|February 12, 2008
Antinociceptive effects of high-dose remifentanil in male methadone-maintained patientsJustin L Hay, Jason M White, Felix Bochner, et al.
Drug Testing and Analysis|January 10, 2024
Amphetamine-type drug-related fatalities in the context of 8 years of methamphetamine use measured by wastewater analysis in South AustraliaEmma L Jaunay, Bradley S Simpson, Jason M White, et al.
Pageof 13